Practice Operations · For practice managers
Comparing Cost of Closed System PRP Kits Versus Open Systems
Published November 15, 2026
- Primary Cost Drivers
- Consumables, Labor & Risk
- Regulatory Pathway
- FDA 510(k) Clearance
- Fluid Pathway Exposure
- Zero Ambient Air Contact
Total cost per PRP procedure encompasses direct kit pricing, ancillary draw supplies, staff processing time, and regulatory compliance exposure.
Devices intended for the point-of-care preparation of autologous platelet-rich plasma are regulated by the FDA under the 510(k) medical device framework.
Closed PRP systems maintain biological isolation from venipuncture through centrifugation and syringe extraction to preserve sterility.
When comparing cost of closed system PRP kits versus open systems, practice managers must evaluate total cost per procedure rather than raw consumable pricing alone. While open systems using standard laboratory blood collection tubes carry a lower upfront unit cost, FDA-cleared closed systems reduce hands-on staff processing time, minimize contamination liability, and eliminate the need for specialized sterile hood infrastructure. For most outpatient regenerative clinics, the operational efficiency and regulatory compliance of closed systems offset their higher per-kit acquisition cost.
Defining Open vs. Closed PRP Preparation Systems
Before auditing spreadsheet expenses, procurement leads and medical directors must align on the technical and regulatory distinctions between preparation methods. Platelet-rich plasma (PRP) is classified by the FDA under regulatory frameworks governing blood products and medical devices, specifically utilizing the 510(k) clearance pathway for preparation systems.
What Constitutes an Open System?
An open PRP system relies on general-purpose laboratory tubes—frequently basic ACD-A or sodium citrate vacutainers—that are not specifically cleared by the FDA for preparing homologous re-injection products at the point of care. During processing, the technician or clinician must uncap the tubes, manually pipette or decant plasma layers across multiple vessels, and expose the biological sample to ambient room air. Because the fluid pathway is exposed to the environment, maintaining strict asepsis requires rigorous manual technique and controlled environmental air quality.
What Constitutes a Closed System?
A closed PRP system is an integrated, purpose-built medical device kit wherein the blood draw, centrifugation, and platelet isolation occur entirely within a sealed, sterile fluid pathway. Transfers between chambers or syringes happen via needleless Luer-lock valves, specialized mechanical separators, or internal buoy mechanisms without exposing the blood components to ambient air. These systems are specifically engineered and cleared for point-of-care autologous preparation.
Breaking Down the True Cost Per Procedure
When practice administrators conduct a financial analysis comparing cost of closed system PRP kits versus open systems, looking solely at the distributor invoice creates a distorted financial picture. A comprehensive cost-per-treatment model must incorporate direct consumables, ancillary supplies, labor allocation, and risk mitigation.
Direct Consumable Expenses
Open systems undeniably present a lower initial invoice line item. Standard laboratory blood collection tubes are mass-produced commodities designed for diagnostic pathology, not therapeutic re-implantation. However, an open protocol rarely stops at the cost of a single tube. Administrators must tally the secondary consumables required to complete the draw and manual separation: multiple transfer pipettes, secondary spin tubes, separate vials of anticoagulant, drawing needles, butterfly sets, and final injection syringes.
Closed systems bundle these components into a single unit-of-use package. While the upfront price per kit is higher, it consolidates procurement into a single SKU and eliminates hidden per-procedure wastage of ancillary medical supplies.
Labor, Workflow, and Room Turnover
Staff time is frequently the largest uncalculated variable in regenerative medicine operations. Open systems require a skilled medical assistant, phlebotomist, or nurse to perform delicate manual pipetting after centrifugation. If the technician draws too aggressively, red blood cells contaminate the buffy coat; if they draw too conservatively, viable platelets are discarded. This manual intervention takes uninterrupted staff time and occupies the preparation area.
Closed systems standardize the separation mechanics. Utilizing calibrated mechanical gates, gel separators, or precision port systems, a closed kit allows the operator to isolate the platelet concentrate rapidly and predictably. Reducing hands-on processing time frees clinical support staff to room the next patient, prepare ultrasound guidance equipment, or assist the physician, directly improving daily patient throughput.
Compliance, Liability, and Infrastructure Costs
From a risk management perspective, exposing autologous blood to ambient clinic air during manual pipetting introduces a vector for microbial contamination. To mitigate this risk properly in an open workflow, practices technically require laminar flow hoods, certified cleanroom environments, and intensive staff validation protocols—infrastructure expenses that quickly erase the savings of cheap laboratory tubes.
Furthermore, utilizing diagnostic blood tubes for therapeutic injection constitutes an off-label use of a laboratory device. If an adverse event or joint infection occurs, the practice's malpractice defense is significantly more complex if the clinic bypassed FDA-cleared biologics preparation devices simply to reduce consumable costs.
Operational and Financial Comparison Checklist
Practice managers evaluating vendor contracts can use the following operational parameters to compare total system value:
- Upfront Consumable Cost: Open systems offer low per-tube commodity pricing but require separate purchasing of needles, syringes, transfer pipettes, and anticoagulant; closed systems have a higher unified kit price with all necessary capture and isolation components included.
- Regulatory Standing: Open lab tubes are generally cleared for in-vitro diagnostic testing only; closed PRP kits carry specific 510(k) clearance for point-of-care autologous preparation.
- Sterility Assurance: Open systems expose the biological specimen to ambient room air during decanting; closed systems maintain a sealed fluid pathway from venipuncture to syringe extraction.
- Staff Training & Labor: Open protocols require high manual dexterity and longer hands-on processing times; closed protocols utilize mechanical separation that minimizes technician variability and speeds up workflow.
- Inventory Management: Open setups require tracking a dozen separate ancillary SKUs with varying expiration dates; closed kits consolidate purchasing, tracking, and lot-number documentation into one barcode.
- Patient Perception: Drawing blood into standard diagnostic tubes can appear improvised to discerning cash-pay patients; purpose-built closed medical device kits reinforce the clinical professionalism of a premium self-pay procedure.
Clinical Considerations for Physicians: Yield, Purity, and Reproducibility
While practice administrators focus on margins and workflow, treating physicians across specialties such as orthopedics, sports medicine, and aesthetics must evaluate how the preparation method impacts clinical outcomes. A low-cost open protocol that fails to deliver a therapeutic platelet dose ultimately harms the practice through poor patient retention and reputational damage.
Controlling the Cellular Composition
Different clinical indications require tailored cellular profiles. For example, intra-articular orthopedic injections often call for leukocyte-poor PRP to minimize acute post-injection inflammatory flares, whereas certain tendon or soft-tissue protocols may utilize leukocyte-rich formulations. Similarly, erythrocytes (red blood cells) are widely considered detrimental in intra-articular and dermal applications due to oxidative stress and hemosiderin staining.
In an open system, separating the platelet-rich buffy coat from the underlying red blood cell pack relies entirely on the visual acuity and steady hand of the operator. Even minor variations in pipetting technique lead to wildly inconsistent platelet yields and unintended red blood cell contamination from one visit to the next.
Closed systems engineer this variability out of the workflow. By utilizing precision-weighted buoys, calibrated centrifugation chambers, or dual-spin mechanical locks, closed kits allow physicians to achieve reproducible platelet concentrations and predictable leukocyte inclusion or exclusion regardless of which staff member processes the draw. When combining PRP with advanced modalities like extracorporeal shockwave therapy or laser devices, knowing the exact biological profile of the injectate is essential for standardizing clinical protocols.
Evaluating Vendor Partnerships and Supply Chain Stability
Transitioning to or optimizing a closed PRP system does not mean accepting inflated equipment leases or restrictive minimum order quantities. Many legacy manufacturers lock clinics into expensive capital centrifuge purchases or rigid monthly consumable quotas that strain cash flow during slower seasonal periods.
An experienced distributor helps practices source FDA-cleared closed systems that match their patient volume and clinical focus—whether the clinic needs small-volume kits for facial aesthetics and hair restoration or high-volume dual-spin kits for multi-joint orthopedic procedures. By evaluating the centrifuge footprint, spin times, and per-kit tier pricing, administrators can secure compliant closed systems that protect practice margins.
What This Means for Your Practice
If your clinic is currently utilizing an open tube protocol or re-evaluating your current biologics vendor, take the following steps to audit your true cost per procedure:
- Conduct a Time-Motion Audit: Time your clinical staff from the moment of venipuncture to the final loaded syringe, accounting for every minute spent gathering ancillary supplies and manually pipetting.
- Calculate Fully Burdened Supply Costs: Tally the exact cost of all secondary consumables used in your current setup, including anticoagulant vials, drawing needles, transfer pipettes, sterile drapes, and syringes.
- Review Regulatory Documentation: Verify the FDA clearance status of the tubes currently on your shelves to ensure they are cleared for human in-vivo re-application rather than in-vitro diagnostics.
- Standardize Clinical Protocols: Meet with your medical director to establish whether your current system reliably produces both the volume and cellular profile (leukocyte-rich vs. leukocyte-poor) required for your patient population.
To review FDA-cleared PRP systems, compare unit economics for your specific patient volume, or streamline your regenerative supply chain, contact Dallas Regenerative Solutions to schedule an operational consultation with our distribution team.
Frequently asked questions
- Why are closed system PRP kits more expensive upfront than open tube systems?
- Closed system PRP kits are purpose-built medical devices that undergo rigorous FDA 510(k) clearance testing for biocompatibility, sterility, and consistent platelet recovery. Unlike mass-produced diagnostic lab tubes, closed kits include specialized mechanical separation chambers, integrated anticoagulants, and needleless transfer ports that eliminate the need to purchase separate ancillary extraction supplies.
- Can a medical practice use standard laboratory vacutainer tubes to prepare PRP?
- Standard laboratory blood collection tubes are cleared for in-vitro diagnostic testing, not for preparing biological tissues intended for re-injection into a patient. Using diagnostic tubes for therapeutic PRP is considered an off-label application that exposes the blood sample to ambient air during processing and increases the clinic's regulatory and infection-control liability.
- How do closed PRP systems reduce staff labor costs?
- Closed systems utilize automated mechanical separators, calibrated chambers, or buoy systems to isolate the buffy coat and platelet-poor plasma without manual pipetting. This reduces hands-on technician processing time and minimizes the risk of human error, allowing medical assistants to focus on patient care and faster room turnover.
- Do closed PRP kits require a proprietary centrifuge?
- Many closed PRP systems require a specific centrifuge rotor bucket size and programmable spin speed (measured in RCF or g-force) to ensure the internal separation mechanics function accurately. However, distributors can often provide universal-bucket centrifuges or flexible equipment placement programs depending on the practice's monthly kit volume.
- How does a practice manager calculate the ROI of switching to a closed PRP system?
- To calculate ROI, subtract the total cost of the closed kit from the combined cost of open tubes, ancillary drawing supplies, anticoagulant, and the dollar value of staff minutes spent manually processing and cleaning up. Factor in the revenue retention gained from consistent clinical outcomes and reduced compliance exposure to see the complete financial impact.
